$ Value
$0
Shares
14,461
Price
$0
Filed
Jun 20
Insider
Name
Fairmount Funds Management LLC
Title
—
CIK
0001802528
Roles
Transaction Details
Transaction Date
2025-06-17
Code
A
Table
Derivative
Ownership
Indirect
Equity Swap
No
Shares After
14,461
Footnotes
This option represents the right to purchase 14,461 shares of the Issuer's common stock and will vest on the one-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer on such vesting date. | Under Mr. Harwin's arrangement with Fairmount Funds Management LLC ('Fairmount'), Mr. Harwin holds the option for one or more investment vehicles managed by Fairmount (each, a "Fairmount Fund"). Mr. Harwin is obligated to turn over to Fairmount any net cash or stock received from the option for the benefit of such Fairmount Fund. Mr. Harwin therefore disclaims beneficial ownership of the option and underlying common stock. Fairmount disclaims beneficial ownership of any of the reported securities, except to the extent of its pecuniary interest therein. | Under Mr. Kiselak's arrangement with Fairmount, Mr. Kiselak holds the option for one or more Fairmount Funds. Mr. Kiselak is obligated to turn over to Fairmount any net cash or stock received from the option for the benefit of such Fairmount Fund. Mr. Kiselak therefore disclaims beneficial ownership of the option and underlying common stock. Fairmount disclaims beneficial ownership of any of the reported securities, except to the extent of its pecuniary interest therein.
Filing Info
Fairmount Funds Management LLC's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-31 | COGT | C | — |
| 2026-03-31 | COGT | ▼ | $242.6M |
| 2026-03-31 | COGT | C | $0 |
| 2026-03-31 | ZBIO | ▲ | $3.0M |
| 2026-03-23 | DMRA | A | $0 |
| 2026-02-09 | GLTO | M | $0 |
| 2026-02-09 | GLTO | M | $0 |
| 2026-02-09 | GLTO | M | $0 |
| 2026-02-09 | GLTO | M | $0 |
| 2026-01-22 | APGE | ▼ | $133.5M |
Other Insiders at APGE (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Henderson Jane
Chief Financial Officer
|
— | $652K | 2026-04-16 |
|
HENDERSON MICHAEL THOMAS
Chief Executive Officer
|
— | $2.9M | 2026-04-16 |
|
Dambkowski Carl
Chief Medical Officer
|
— | $828K | 2026-04-01 |